Zepzelca

Active Ingredient(s): Lurbinectedin
FDA Approved: * June 15, 2020
Pharm Company: * JAZZ
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zepzelca Overview

Lurbinectedin, sold under the brand name Zepzelca, is a medication for the treatment of adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.[1][2][3] The most common side effects include leukopenia, lymphopenia, fatigue, anemia, neutropenia, increased creatinine, increased alanine aminotransferase, increased glucose, thrombocytopenia, nausea, decreased appetite, musculoskeletal pa...

Read more Zepzelca Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lurbinectedin

Recent Zepzelca Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lurbinectedin
  • Powder: 4mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zepzelca: (1 result)

Sorted by National Drug Code
  • 68727-712 Zepzelca .5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Jazz Pharmaceuticals, Inc.

Other drugs which contain Lurbinectedin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA